Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma

BACKGROUND: Melphalan is one of the most active chemotherapeutic agents in the treatment of multiple myeloma (MM). However, the mechanism underlying differential patient responses to melphalan therapy is unknown. METHODS: Chromatin structure, transcriptional activity and DNA damage response signals...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Gkotzamanidou, M, Sfikakis, P P, Kyrtopoulos, S A, Bamia, C, Dimopoulos, M A, Souliotis, V L
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2014
Onderwerpen:
Clinical Study
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4183844/
https://ncbi.nlm.nih.gov/pubmed/25051404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.410
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items